Literature DB >> 8019370

Architectural pattern of the normal and cancerous breast under the influence of parity.

J Russo1, A L Romero, I H Russo.   

Abstract

Epidemiological and clinical observations indicate that breast cancer incidence is greater in nulliparous women, whereas early parity confers protection. Since the initiation of breast cancer is related to the degree of development of the organ, this study was designed with the purpose of determining what basic differences exist between the parous and the nulliparous women's breast, and whether these differences correlated with the presence or absence of malignancies. For this purpose, the architecture of the mammary gland of parous and nulliparous women with breast cancer was compared with that of women free of mammary pathology. The women ranged in an age from 20 to 63 years. Normal whole breasts obtained at autopsy or cancer-bearing breasts surgically removed by modified radical mastectomy were studied in whole mount preparations in which the number and relative proportion of normal structures, i.e., lobules type 1, 2, and 3 (Lob 1, 2, and 3), were determined. In the breast of nulliparous women, the predominant structure present was the Lob 1; the presence of cancer did not modify the basic architectural pattern of the breast, which contained a higher proportion of Lob 1, as well. In parous women free of cancer, the breast contained a greater percentage of Lob 3 and a moderately increased number of Lob 2, with a concomitant reduction in Lob 1. Parous women with breast cancer, on the other hand, exhibited a different architecture in the mammary gland, which had a greater percentage of Lob 1 and a lower of Lob 3 than the noncancerous group, approaching the percentages found in nulliparous women.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1994        PMID: 8019370

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  19 in total

1.  Estrogen induced breast cancer is the result in the disruption of the asymmetric cell division of the stem cell.

Authors:  Jose Russo; Kara Snider; Julia S Pereira; Irma H Russo
Journal:  Horm Mol Biol Clin Investig       Date:  2010-01-01

2.  Tamoxifen downregulates ets oncogene family members ETV4 and ETV5 in benign breast tissue: implications for durable risk reduction.

Authors:  David Euhus; Dawei Bu; Xian-Jin Xie; Venetia Sarode; Raheela Ashfaq; Kelly Hunt; Weiya Xia; Joyce O'Shaughnessy; Michael Grant; Banu Arun; William Dooley; Alexander Miller; David Flockhart; Cheryl Lewis
Journal:  Cancer Prev Res (Phila)       Date:  2011-07-21

3.  Lobule type and subsequent breast cancer risk: results from the Nurses' Health Studies.

Authors:  Heather J Baer; Laura C Collins; James L Connolly; Graham A Colditz; Stuart J Schnitt; Rulla M Tamimi
Journal:  Cancer       Date:  2009-04-01       Impact factor: 6.860

Review 4.  Timing of dietary fat exposure and mammary tumorigenesis: role of estrogen receptor and protein kinase C activity.

Authors:  L Hilakivi-Clarke; R Clarke
Journal:  Mol Cell Biochem       Date:  1998-11       Impact factor: 3.396

5.  Absence of the common IGF1 19 CA-repeat allele is more common among BRCA1 mutation carriers than among non-carriers from BRCA1 families.

Authors:  Maria Henningson; Erika Bågeman; Therese Sandberg; Ake Borg; Håkan Olsson; Helena Jernström
Journal:  Fam Cancer       Date:  2007-05-05       Impact factor: 2.375

6.  Benign breast tissue composition in breast cancer patients: association with risk factors, clinical variables, and gene expression.

Authors:  Xuezheng Sun; Rupninder Sandhu; Jonine D Figueroa; Gretchen L Gierach; Mark E Sherman; Melissa A Troester
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-09-23       Impact factor: 4.254

Review 7.  The protective role of pregnancy in breast cancer.

Authors:  Jose Russo; Raquel Moral; Gabriela A Balogh; Daniel Mailo; Irma H Russo
Journal:  Breast Cancer Res       Date:  2005-04-07       Impact factor: 6.466

Review 8.  Mammary gland neoplasia in long-term rodent studies.

Authors:  I H Russo; J Russo
Journal:  Environ Health Perspect       Date:  1996-09       Impact factor: 9.031

9.  Automated Quantitative Measures of Terminal Duct Lobular Unit Involution and Breast Cancer Risk.

Authors:  Rulla M Tamimi; Yujing J Heng; Kevin H Kensler; Emily Z F Liu; Suzanne C Wetstein; Allison M Onken; Christina I Luffman; Gabrielle M Baker; Laura C Collins; Stuart J Schnitt; Vanessa C Bret-Mounet; Mitko Veta; Josien P W Pluim; Ying Liu; Graham A Colditz; A Heather Eliassen; Susan E Hankinson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-09-11       Impact factor: 4.254

10.  Intrauterine environment, mammary gland mass and breast cancer risk.

Authors:  Dimitrios Trichopoulos
Journal:  Breast Cancer Res       Date:  2002-11-07       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.